On Monday, 30 November 2020 at 4 PM – 5 PM CET we will host our webinar #41 on the results of the world largest prospective, multicentre Flow Diverter Post-Market Clinical Follow-up study to date are presented. The webinar will be moderated by Dr. Demetrius Lopes. Speakers of the webinar will be:
- Prof. Alain Bonafé
- Prof. Peter Schramm
The webinar is supported by phenox and the registration of the webinar is free.
What is the webinar about?
The results of the world largest prospective, multicentre Flow Diverter Post-Market Clinical Follow-up study to date are presented.
Key message
Diversion-p64 demonstrates non-inferiority compared to available flow diverters (FD) in the treatment of a wide range of intracranial aneurysms
Learning objectives
- p64 is a fully retrievable self-expandable nitinol FD
- Safety data for 372 patients of the per protocol population at up to 12 months follow-up
- Complete Core Lab assessed angiographic data-sets for up to 6 months follow-up and up to 12 months patient follow-up
- p64 Flow Modulation Device offers a reliable, safe and effective treatment option for subjects harboring IAs in the anterior circulation.
What to expect?
The ESMINT webinar provides you the opportunity to meet experts, who share with you their experience, practice, and way of thinking regarding everyday challenges in the field of neurointerventions.
The webinar will be an interactive live transmission. All participants will be able to ask questions through a live online chat.